The use of second line drugs in patients with drug resistance to standard tuberculostatics.
D000553:Ambulatory Care; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects; D003523:Cycloserine / Q000008:administration & dosage*; D004342:Drug Hypersensitivity / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000008:administration & dosage*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000008:administration & dosage*; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D011718:Pyrazinamide; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin